| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.33 | 0.002 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.24 | 0.07 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |